Meds for Renal and Hepatic Disease Flashcards
Hyperkalemia in CKD
Considered at levels > 5 mEq/L
Renal potassium is increased by aldosterone, diuretics (loop>thiazide)
Pts with DM are at an increased risk due to insulin deficiency reducing the ability to shift potassium into the cell
Metronidazole
Dont use long term due to peripheral neuropathies
Harvoni (Sofosbuvir and Ledpasvir)
Potentially serious drug interactions
- Acid suppression therapy should be avoided or minimized during therapy
- Approved for HCV/HIV co infection
- Approved for children >=12 years old for certain genotypes
NRTI drug interactions
- Ribavirin can increase hepatotoxic effects of all NRTIs lactic acidosis can occur
- Lamivudine Bactrim can increase lamuvidine levels due to decreased excretion
- Tenofovir fumarate: avoid concurrent treatment with didanosine or adefovir due to increased risk of virologic failure and increased side effects
- Tenofovir alefenamide is a P-gp substrate avoid use with oxcarb, phenytoin, phenobarb, rifampin, St. Johns wart
Aluminum based phosphate binders
Aluminum Hydroxide
Potent but rarely used to due to aluminum accumulations which can cause nervous system and bone toxicities
Treatment is limited to 4 wks
SIDE effects: dialysis dementia
Treatment of Alcoholic Liver disease
- Stop drinking
- Use Benzos inpatient to prevent siezures
- Anticonvulsants outpatient
- To prevent Relapse: Naltrexone or Disulfuram
- Vitamins needed: A, D, b1 (thiamine), B6 (pyridoxine), zinc
- Thiamine: To prevent and treat wernicke-korsakoff syndrome
Ribavirin:
- Teratogenic effects, not effective for HCV monotherapy, hemolytic anemia mostly occuring within 4 wks
- Contraindicated in pregnancy: women of childbearing agae who will not use contraception reliabily, male partners of pregnant women, hemoglobinopathies, CrCl<50, concomitant use with didanosine
- SEs: Hemolytic anemia,
- Notes: Avoid in pregnancy, females and female partners of male patients and 6 months after treatment. At least 2 forms of contraception required during treatment and in the 6 month post treatment period.
Ribavirin DIs and Counseling
Dont use with didanosine fatal hepatic failure, peripheral neuropathy and pancreatitis
COUNSELING:
- Can cause birth defects
Calcimimetics
Cincacalcet (Sensipar)
Hypocalemia
Etelcalcetide (Parsabiv): warning for hypocalemia, muscle spasms, paresthesia (burning sensation on skin)
NRTI counseling
Epivir tablets and oral solution are not interchangeable
- Entacavir: food decreases absorption of this drug take on an empty stomach 2 hours before or after meal
- Lactic acidosis is possible, contact doctor if having stomach pain with nausea/vomiting, unusual muscle pain, dizzy or lightheaded
- Lamuvidine: same people have developed pancreatitis, see doctor if having upper abdominal pain
Technivie (Paritaprevir, ritonavir, ombitasvir), Viekra
- Contraindications: Moderate-severe hepatic impairment (Child Pugh B or C), concomitant use of drugs dependent on 3A4, all ritonavir contraindications are included here.
- Warnings: Hepatic decompensation and hepatic failure in pt with cirrhosis risk of LIFT increase(>5 x ULN) within 4 wks of treatment (female pts taking ethinyl estradiol products are at increased risk) drug interactions, HIV protease inhibitor resistance
Lamivudine (Epivir)
- Do not use for treatment of HIV can result in HIV resistance
What can limit the need for blood transfusions in CKD anemia
ESA
Erythropoeisis Stimulating Agents
- Epoetin Alfa (procrit,epogen) and longer lasting darbepoetin (Aranesp)
- Risks: elevated blood pressure, should only be used inf Hgb <10g/dL
- Then should be held if hgb exceeds 11
- Only works if there is enough Iron so look at iron levels
10 select drugs that cause kidney disease
- NSAIDs
- Aminoglycosides
- Vancomycin
- Amphotericin B
- Cisplatin
- Cyclosporine
- Loop diuretics
- Polymyxins
- Radiographic contrast dye
- Tacolimus
Treatement of Hyperkalemia
DC in potassium agents
Stabilize the mycardial cells and to rapidly shift potassium in cells or eliminate
- Stabilize heart with calcium gluconate
- Move K into cells, regular insulin, dextrose, sodium bicarb, ALbuterol
- Remove it: Furosemide, Sodium polystyrene, Patiromer, zirconium, hemodialysis
Tenofovir fumarate (VIread TDF)
Tenofovir alafenamide (TAF), vemlidy
- Renal toxicity including acute renal failure or Fanconi syndrome, osteomalacia, and Decreased bone mineral density
- Dispense in original container
Rifaximin
SEs: peripheral edema, dizziness fatigue
Simepravir
- Dont administer with strong CyP3A4 inducers and erythromycin, clarithromycin, azole antifungals, calcium channel blockers, numerous HIV meds, cisapride, cyclosporine, sirolimus, PDE-5 inhibitors for PAH, triazolam, or midazolam
- Inhibits P-Gp can increase concentrations of P=Gp substrates (dabigatran)
Child-Pugh Scores
- A mild: score <7
- B 7-9
- C: 10-15
- Generally dosing cautions at Grade C
Entecavir
Baraclude
Take on an Empty stomach
Nonselective beta blockers for the treatment of variceal bleeding
Propranolol and Nadolol
- Maximize till tolerated target HR 55-60 BPM
- Do not withdrawal abruptly
- Use caution with patients with Asthma or COPD
- Monitor BP and HR
*
Neomycin
Neurotoxicity (hearing loss, vertigo),
GI upset
Mavyret (glecaprevir, pibrentasvir)
- Approved for 8 wk course in specific patients
- Approved with HIV coinfection
- Approved for salvage therapy, failed previous therapy
Lanthanum
Al free Ca free
SEs: N/V/D/constipation
Must chew thoroughly to reduce risk of significant GI effects
Epclusa (sofosbuvir and velpatasvir)
- Pan-genotypic approved for all genotypes (Epclusa and mavyret)
- Approved for HIV/HCV co infections